NASDAQ: KIDS
Orthopediatrics Corp Stock Ownership - Who owns Orthopediatrics?

Insider buying vs selling

Have Orthopediatrics Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Daniel J. GerritzenGeneral Counsel and Secretary2024-08-2110,000$29.30
$293.00kSell

1 of 1

KIDS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KIDS insiders and whales buy or sell their stock.

KIDS Shareholders

What type of owners hold Orthopediatrics Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
David R. Pelizzon56.94%13,828,075$346.81MInsider
Squadron Capital LLC28.42%6,901,764$173.10MInsider
Brown Capital Management LLC7.75%1,882,405$47.21MInstitution
Brown Advisory Inc6.32%1,534,028$38.47MInstitution
Blackrock Inc5.18%1,259,173$31.58MInstitution
Braidwell LP4.56%1,107,770$27.78MInstitution
Wellington Management Group LLP4.37%1,061,299$26.62MInstitution
Morgan Stanley4.09%992,299$24.89MInstitution
Vanguard Group Inc3.80%923,890$23.17MInstitution
Granahan Investment Management LLC3.24%786,369$19.72MInstitution

1 of 3

KIDS vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KIDS43.19%56.81%Net Selling
SIBN56.69%43.31%Net SellingNet Selling
OFIX84.69%14.47%Net BuyingNet Selling
BFLY29.80%39.05%Net SellingNet Selling
AVNS93.76%3.38%Net SellingNet Selling

Orthopediatrics Stock Ownership FAQ

Who owns Orthopediatrics?

Orthopediatrics (NASDAQ: KIDS) is owned by 67.95% institutional shareholders, 89.36% Orthopediatrics insiders, and 0.00% retail investors. David R. Pelizzon is the largest individual Orthopediatrics shareholder, owning 13.83M shares representing 56.94% of the company. David R. Pelizzon's Orthopediatrics shares are currently valued at $346.81M.

If you're new to stock investing, here's how to buy Orthopediatrics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.